GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Capex-to-Operating-Income

Psyence Biomedical (Psyence Biomedical) Capex-to-Operating-Income : 0.00 (As of Mar. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Psyence Biomedical's Capital Expenditure for the six months ended in Mar. 2023 was $0.00 Mil. Its Operating Income for the six months ended in Mar. 2023 was $-3.13 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Psyence Biomedical Capex-to-Operating-Income Historical Data

The historical data trend for Psyence Biomedical's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Capex-to-Operating-Income Chart

Psyence Biomedical Annual Data
Trend Mar21 Mar22 Mar23
Capex-to-Operating-Income
- - -

Psyence Biomedical Semi-Annual Data
Mar21 Mar22 Mar23
Capex-to-Operating-Income - - -

Competitive Comparison of Psyence Biomedical's Capex-to-Operating-Income

For the Biotechnology subindustry, Psyence Biomedical's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Biomedical's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Psyence Biomedical's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Psyence Biomedical's Capex-to-Operating-Income falls into.



Psyence Biomedical Capex-to-Operating-Income Calculation

Psyence Biomedical's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -3.125
=N/A

Psyence Biomedical's Capex-to-Operating-Income for the quarter that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -3.125
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Biomedical  (NAS:PBM) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Psyence Biomedical Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Biomedical (Psyence Biomedical) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines